100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study

Dr. Andrea Cercek, one of the lead researchers, said:

“It’s absolutely incredible … We’ve certainly never seen this before.”

All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody.

This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies.

The authors wrote:

“All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging … and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.”

How does this monoclonal antibody actually work?

Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

Watch the Full Video

---

SUPPORT THE SHOW THROUGH OUR SPONSORS:

1.) My Patriot Supply: https://bit.ly/Prepare-With-VNN

2.) Done With Debt: https://www.donewithdebt.com

3.) Field of Greens: https://brickhousenutrition.com/pages/vnn

• Promo Code VNN to save 15%

4.) Allegiance Gold: https://www.allegiancegold.us/brics-poised-to-overtake-us-dollar-sf-vnn/